CD55-deficient protein-losing enteropathy
Clinical trials for CD55-deficient protein-losing enteropathy explained in plain language.
Never miss a new study
Get alerted when new CD55-deficient protein-losing enteropathy trials appear
Sign up with your email to follow new studies for CD55-deficient protein-losing enteropathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug offered to patients with rare gut condition
Disease control ApprovedThis study provides compassionate access to pozelimab for people with CD55-deficient protein-losing enteropathy, a rare condition where the gut leaks proteins. The goal is to offer an experimental treatment option when no other therapies are available. Participants receive the dr…
Matched conditions: CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Lifesaving drug now available for kids with rare gut disease
Disease control ApprovedThis program gives patients with CHAPLE disease, a rare and life-threatening immune disorder that causes protein loss from the gut, access to the experimental drug pozelimab. The goal is to provide treatment and monitor long-term safety. Participants must have a confirmed genetic…
Matched conditions: CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC